`
`
`
`
`
`Case No. IPR2018-01341
`Patent No. 9,393,208
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`DR. REDDY’S LABORATORIES INC.,
`Petitioner
`
`v.
`
`POZEN, INC. and HORIZON PHARMA USA, INC.
`Patent Owners
`
`
`
`Case No. IPR2018-01341
`Patent No. 9,393,208
`
`
`
`
`
`
`
`PATENT OWNERS’ EXHIBIT LIST
`
`
`
`
`
`Case No. IPR2018-01341
`Patent No. 9,393,208
`
`PATENT OWNER’S EXHIBIT LIST
`
`Description of Document
`
`Gabriel, S.E., et al., “Risk for Serious Gastrointestinal
`Complications Related to Use of Nonsteroidal Anti-
`inflammatory Drugs,” Annals of Internal Medicine, Vol.
`115, No. 10, pp. 787-796 (1991) (“Gabriel”)
`
`Cryer, B. and Feldman, M., “Effects of Nonsteroidal
`Anti-inflammatory Drugs on Endogenous
`Gastrointestinal Prostaglandins and Therapeutic
`Strategies for Prevention and Treatment of Nonsteroidal
`Anti-inflammatory Drug-Induced Damage,” Archives of
`Internal Medicine, Vol. 152, pp. 1145-1155 (1992)
`(“Cryer”)
`
`Fries, J.F., et al., “Nonsteroidal Anti-Inflammatory Drug-
`Associated Gastropathy: Incidence and Risk Factor
`Models,” The American Journal of Medicine, Vol. 91,
`pp. 213-222 (1991) (“Fries”)
`
`U.S. Patent No. 9,220,698 Prosecution History Excerpt:
`Response to Final Office Action Mailed March 26, 2015
`(Sept. 25, 2015)
`
`U.S. Patent No. 9,220,698 Prosecution History Excerpt:
`Advisory Action (Oct. 9, 2015)
`
`Horizon Pharma, Inc. v. Dr. Reddy’s Laboratories, Inc.,
`Case No. 2:15-cv-03324 (SRC), Opinion and Order (D.I.
`82) (Nov. 14, 2017)
`
`Horizon Pharma, Inc. v. Dr. Reddy’s Laboratories, Inc.,
`Case No. 2:15-cv-03324 (SRC), Opinion (D.I. 162)
`(Nov. 19, 2018)
`
`Exhibit Number
`
`2001
`
`2002
`
`2003
`
`2004
`
`2005
`
`2006
`
`2007
`
`2008-2072
`
`Exhibits Not Used
`
`1
`
`
`
`
`
`
`
`
`
`
`
`
`Exhibit Number
`
`2073
`
`2074
`
`2075
`
`2076
`
`2077
`
`
`
`Date: February 8, 2019
`
`COOLEY LLP
`ATTN: Patent Group
`1299 Pennsylvania
`Avenue, N.W Suite 700
`Washington, DC 20004-2400
`Tel: 720-566-4119
`Fax: 720-566-4099
`
`
`
`
`
`
`Case No. IPR2018-01341
`Patent No. 9,393,208
`
`Description of Document
`
`Opinion & Order, filed on November 14, 2017 in
`Horizon Pharma, Inc. v. Dr. Reddy’s Laboratories, Inc.,
`Civ. A. No. 2:15-cv-03324-SRC-CLW (SRC)
`Memorandum of Mylan and DRL in Support of Their
`Motion for Summary Judgment of Invalidity of U.S.
`Patent Nos. 9,220,698 and 9,393,208, filed on November
`12, 2018 in Horizon Pharma, Inc. v. Dr. Reddy’s
`Laboratories, Inc., Civ. A. No. 2:15-cv-03324-SRC-
`CLW (SRC)
`Opinion, filed on November 19, 2018 in Horizon
`Pharma, Inc. v. Dr. Reddy’s Laboratories, Inc., Civ. A.
`No. 2:15-cv-03324-SRC-CLW (SRC)
`Final Judgment Under Rule 54(b), signed and filed
`January 22, 2019 in Horizon Pharma, Inc. v. Dr. Reddy’s
`Laboratories, Inc., Civ. A. No. 2:15-cv-03324-SRC-
`CLW (SRC)
`Final Judgment Under Rule 54(b), signed and filed
`January 22, 2019 in Horizon Pharma, Inc. v. Dr. Reddy’s
`Laboratories, Inc., Civ. A. No. 2:15-cv-03324-SRC-
`CLW (SRC)
`
`Respectfully submitted,
`
`By: /Thomas A. Blinka/
`Thomas A. Blinka
`Reg. No. 44,541
`Counsel for Patent Owner
`
`2
`
`
`
`
`
`
`
`Case No. IPR2018-01341
`Patent No. 9,393,208
`
`CERTIFICATE OF SERVICE UNDER 37 C.F.R. § 42.6(e)
`
`I, Thomas A. Blinka, hereby certify that on this 8th day of February, 2019,
`
`the foregoing Patent Owner’s Exhibit List was served electronically via email on
`
`the following:
`
`Alan Pollack
`apollack@buddlarner.com
`
`
`Louis Weinstein
`lweinstein@buddlarner.com
`
`BUDD LARNER PC
`150 John F. Kennedy Parkway
`Short Hills, New Jersey 07078
`Tel: (973) 379-4800
`
`Date: February 8, 2019
`
`
`
`By: /Thomas A. Blinka/
`Thomas A. Blinka
`Reg. No. 44,541
`Counsel for Patent Owner
`
`
`
`
`
`3
`
`